People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Attralus, Inc. | — | Biotechnology | Series D+ | $172.8M | $708.5M | 2024 |
| Collections Marketing Center, Inc. | — | Other Technology | Series A | $24.3M | $210.8M | 2015 |
Gregory Bell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gregory Bell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Corey Goodman | 1 | 13 |
| Richard Gaster | 1 | 7 |
| Morgan Rodd | 1 | 4 |
| Richard M. Berkeley | 1 | 3 |
| Mehdi Khodadad | 1 | 3 |
| Rahul Kakkar | 1 | 3 |
| Robert S. Adelson | 1 | 3 |
| Ye Zhang | 1 | 2 |
| Manny Fernandez | 1 | 2 |
| Vytas Kisielius | 1 | 2 |
| Jake Bauer | 1 | 2 |
| F. Morgan Rodd, Jr. | 1 | 2 |
| Ralph Clark | 1 | 2 |
| Nathaniel Lentz | 1 | 2 |
| Greg Bell | 1 | 2 |
| Jonathan Wall | 1 | 2 |
| Ralph M Clark | 1 | 1 |
| Dawn Willey | 1 | 1 |
| Nathaniel Morgan Lentz | 1 | 1 |
| Pat Ouredik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.